Nationwide Recall of Wedgewood Veterinary Medications Over Potency Concerns

Wedgewood Pharmacy, a compounding company that produces custom medicines for animals, announced a voluntary recall of a broad range of its products on Wednesday. The decision comes after the firm’s own quality‑control team uncovered irregularities in analytical testing data, leaving the company unsure whether some batches were too weak to treat a pet or, conversely, strong enough to cause toxicity.

According to a statement posted on Wedgewood’s website, the inconsistency “affects our confidence in the testing data.” When the confidence level dips below the company’s own standards, Wedgewood says the responsible thing to do is to pull the affected lots from the market. The FDA echoed the sentiment, noting that the recalled items are still within their labeled expiration dates, but the reliability of the potency data can’t be guaranteed.

So far the FDA has logged 98 complaints about the recalled medications, seven of which it classified as “serious.” Veterinarians and pet owners who suspect a problem are urged to contact their animal health professional right away.

What’s being recalled? The recall spans products shipped nationwide between Feb. 18 and Oct. 6, 2026. It includes powders, pastes, suspensions, injectables, eye and ear treatments, sprays and gels. The items were formulated for a wide array of patients – from household cats and dogs to horses, exotic zoo animals, wildlife and even aquatic species. They are explicitly not intended for food‑producing animals.

The FDA’s notice provides a downloadable list that details each affected product, complete with lot numbers and expiration dates. Anyone who bought or was prescribed a Wedgewood medication should check that list carefully.

What should you do? If you have a medication that appears on the list, stop using it immediately. Keep the product handy and call Wedgewood’s recall hotline at 866‑562‑5931. Their call center is open Monday‑Friday, 8 a.m.‑9 p.m. ET, and Saturday, 9 a.m.‑5 p.m. ET. Wedgewood is working with recall‑management firm Sedgwick to email and mail notifications, and they will arrange refunds or, when possible, replacements.

Veterinary clinics, pharmacies and other commercial customers are asked to quarantine any suspect inventory right away and to notify any clients who may have already received the products. The FDA also reminds the public that adverse reactions can be reported by calling 1‑888‑FDA‑VETS or submitting a report online at www.fda.gov/reportanimal.

While the recall is unsettling, experts say it underscores the importance of rigorous testing in the compounding industry. “When you’re dealing with living creatures, even a small deviation in dosage can have big consequences,” said Dr. Maya Patel, a veterinary pharmacology professor at the University of Massachusetts. Pet owners are encouraged to stay in touch with their veterinarians and to keep an eye on any future communications from Wedgewood or the FDA.